Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: A systematic review
出版年份 2020 全文链接
标题
Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: A systematic review
作者
关键词
-
出版物
Expert Review of Anti-Infective Therapy
Volume -, Issue -, Pages 1-9
出版商
Informa UK Limited
发表日期
2020-11-14
DOI
10.1080/14787210.2021.1848545
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Recent discovery and development of inhibitors targeting coronaviruses
- (2020) Thanigaimalai Pillaiyar et al. DRUG DISCOVERY TODAY
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province
- (2020) Kui Liu et al. CHINESE MEDICAL JOURNAL
- Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19
- (2020) Adarsh Bhimraj et al. CLINICAL INFECTIOUS DISEASES
- Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia
- (2020) Ruggero Capra et al. European Journal of Internal Medicine
- Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection
- (2020) Dan Yan et al. EUROPEAN RESPIRATORY JOURNAL
- Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review)
- (2020) George Nitulescu et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose?
- (2020) Sara Baldelli et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
- (2020) Zhen Zhu et al. JOURNAL OF INFECTION
- Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
- (2020) Lisi Deng et al. JOURNAL OF INFECTION
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
- (2020) Cynthia Liu et al. ACS Central Science
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression
- (2020) Fang Liu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Lopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection
- (2020) Periklis Panagopoulos et al. JOURNAL OF CHEMOTHERAPY
- A comparative study on the time to achieve negative nucleic acid testing and hospital stays between danoprevir and lopinavir/ritonavir in the treatment of patients with COVID‐19
- (2020) Zhicheng Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- Lopinavir/ritonavir is associated with pneumonia resolution in COVID‐19 patients with influenza coinfection: A retrospective matched‐pair cohort study
- (2020) Chong Yu et al. JOURNAL OF MEDICAL VIROLOGY
- Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019
- (2020) Ji-Won Kim et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- 2491. Post-Exposure Prophylaxis With Ribavirin Plus Lopinavir/Ritonavir for Middle East Respiratory Syndrome in Healthcare Workers
- (2018) So Yeon Park et al. Open Forum Infectious Diseases
- Lopinavir/ritonavir in the treatment of HIV-1 infection: a review
- (2016) Jonathan Shuter Therapeutics and Clinical Risk Management
- Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
- (2015) Jasper Fuk-Woo Chan et al. JOURNAL OF INFECTIOUS DISEASES
- Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
- (2014) Adriaan H. de Wilde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started